The rising affordability of hair transplants abroad has become a key factor motivating many UK patients to seek treatment overseas. However, this trend also brings significant health risks, highlighting the urgent need for stringent regulations to ensure patient safety and protection.
While modern FUE hair transplants are minimally invasive, the procedure is not without risks. When performed improperly, it can lead to serious complications such as scarring, over harvesting of the donor area, infections, scalp necrosis, and poor results — all of which may leave patients with lasting physical and emotional consequences.
In light of this, Longevita Hair Transplant’s founder and CEO, Kagan Seymenoglu, has proposed the adoption of several policies that are aimed at improving patient safety and decision-making processes.
Establishment of an Independent Accreditation Body — Through a UK Medical Tourism Accreditation Association (UKMTAA), an independent regulatory body, the clinical governance, safety protocols, and patient care standards of overseas clinics and clinicians would be formally recorded. This information would then be made available to patients in a centralised database, which they can use to:
- Find trusted healthcare facilitators and make informed decisions.
- Make complaints against the provision of poor-quality care, violations of safety or breaches of contract.
Introduction of Mandatory Medical Tourism Insurance — Before travelling overseas for elective surgery, patients should be required to obtain medical tourism insurance. It will help UK patients by:
- Removing the financial burden of corrective surgery in the event of a botched operation.
- Providing coverage for surgical risks, repatriation in case of emergency and aftercare.
Provision of Integrated Aftercare within the UK — UK patients who seek surgery abroad do not have to worry about being left in a lurch back home with the availability of mandatory aftercare support, which will include follow-ups, monitoring for complications and wound management. Under the proposed regulation, overseas healthcare facilitators will be required to form partnerships with UK-registered clinicians, and patients will benefit from:
- Better standards of healthcare
- Reduced risk of complications
- Better treatment outcomes
Honesty and Responsibility in Marketing Practices — A healthcare facilitator’s marketing materials should include a logo and registration number of UKMTAA in order to indicate compliance with UK healthcare standards, as well as its accreditation. For patients, this will further entail:
- Finding trusted facilitators more easily
- Reducing the need for corrective treatment(s) from the NHS
It is also recommended that the disclosure of risks associated with a certain procedure be made mandatory in medical tourism marketing. Additionally, legal accountability and financial penalties should be instituted to curtail misleading advertising.
Cutting it fine
By Kagan Seymenoglu. CEO, Longevita
